The Centers for Disease Control and Prevention (CDC) is warning those who take medication for ADHD, attention-deficit/hyperactivity disorder, could face a disruption in accessing care after two executives were arrested for a $100 million fraud scheme.
The CDC issued a health advisory to inform public health officials, clinicians and patients about the potential for medication distribution to be affected.
The Department of Justice (DOJ) released information Thursday on the arrests of a California-based digital health company’s CEO and clinical president.
The duo was arrested for their alleged participation in attempting to distribute Adderall over the internet, commit health care fraud by submitting false claims for reimbursement for the drug, and obstructing justice, the DOJ’s release said.
I’m a pharmacist. This is mostly not true. There is a way to transfer it under very specific circumstances. However the majority of pharmacies do not have the appropriate functionality within their software to do so.
That’s by intentional design choice though.
Under very specific circumstances what circumstances? The DEA’s regulations is pretty cut and dry. A patient can request the transfer of a schedule II prescription on a one-time basis.
Also how is it that “the majority of pharmacies do not have the appropriate functionality within their software to do so.” when NCPDP’s SCRIPT standard version 2017071 has that feature according to the DEA and NCPDP and version 2017071 is required if the pharmacy accept Medicaid which a CDC paper says is 90% of pharmacies outside of small rural areas…